Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.55 USD | -2.03% | -.--% | -9.45% |
31/05 | SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%) | |
14/05 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading | MT |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.45% | 1.11TCr | - | ||
+14.21% | 13TCr | A- | ||
-1.95% | 856.48Cr | C | ||
+40.43% | 561.94Cr | B+ | ||
-27.04% | 440.97Cr | C | ||
+7.47% | 341.11Cr | C- | ||
-15.26% | 260.38Cr | B- | ||
-12.01% | 206.72Cr | - | - | |
-13.56% | 192.23Cr | - | ||
-29.81% | 162.92Cr | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- SNNUF Stock
- Ratings Smith & Nephew Plc